United States · FDA National Drug Code directory
AMVUTTRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71336-1003_1791a81a-d261-4b66-b699-273afe02c380
- Product NDC
- 71336-1003
- Form
- INJECTION
- Composition / generic term
- VUTRISIRAN
- Labeler
- Alnylam Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220613
- Source listing expiry
- 20261231
Source-listed ingredients
- VUTRISIRAN SODIUM — 25 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SYRINGE, GLASS · 71336-1003-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →